Leap Therapeutics Inc (LPTX)
2.65
-0.09
(-3.28%)
USD |
NASDAQ |
May 17, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
Leap Therapeutics Total Liabilities (Quarterly): 10.59M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.59M |
| December 31, 2023 | 12.68M |
| September 30, 2023 | 11.04M |
| June 30, 2023 | 11.80M |
| March 31, 2023 | 78.22M |
| December 31, 2022 | 11.49M |
| September 30, 2022 | 12.09M |
| June 30, 2022 | 10.88M |
| March 31, 2022 | 7.344M |
| December 31, 2021 | 10.02M |
| September 30, 2021 | 11.26M |
| June 30, 2021 | 8.056M |
| March 31, 2021 | 7.428M |
| December 31, 2020 | 7.72M |
| September 30, 2020 | 7.406M |
| June 30, 2020 | 7.94M |
| March 31, 2020 | 10.78M |
| December 31, 2019 | 9.197M |
| September 30, 2019 | 8.579M |
| June 30, 2019 | 9.198M |
| Date | Value |
|---|---|
| March 31, 2019 | 9.019M |
| December 31, 2018 | 9.899M |
| September 30, 2018 | 20.50M |
| June 30, 2018 | 22.27M |
| March 31, 2018 | 22.56M |
| December 31, 2017 | 17.94M |
| September 30, 2017 | 5.994M |
| June 30, 2017 | 4.375M |
| March 31, 2017 | 4.612M |
| December 31, 2016 | 106.69M |
| June 30, 2016 | 0.577M |
| December 31, 2015 | 71.55M |
| September 30, 2015 | 2.739M |
| June 30, 2015 | 2.81M |
| March 31, 2015 | 2.821M |
| December 31, 2014 | 2.488M |
| September 30, 2014 | 1.971M |
| June 30, 2014 | 3.195M |
| March 31, 2014 | 2.746M |
| December 31, 2013 | 1.971M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.344M
Minimum
Mar 2022
78.22M
Maximum
Mar 2023
13.19M
Average
10.31M
Median
Total Liabilities (Quarterly) Benchmarks
| Cutera Inc | 504.56M |
| OrthoPediatrics Corp | 66.60M |
| AIM ImmunoTech Inc | 9.147M |
| Protalix BioTherapeutics Inc | 60.04M |
| Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.96M |
| Shareholders Equity (Quarterly) | 47.37M |